Investor Relations

Albany Molecular Research Inc. (AMRI) provides scientific services, technologies and products that improve quality of life while delivering excellence, value and maximum return. AMRI SMARTSOURCING™ is an evolution of AMRI’s business model that puts in context our range of capabilities and technologies across drug discovery and development.

AMRI's core business segments comprise contract research, development and manufacturing.

The fiercely competitive drug discovery industry continues to face many challenges, including a weakening product pipeline, increasing costs and more complex disease targets and regulatory hurdles. These challenges have compelled many companies to look outside their own R&D function for contract partners to support research and development at the earliest stages of the drug discovery process.

With locations in the North America, Europe, and Asia, AMRI provides customers with a wide range of services and cost models.

View Investor Presentation >>

View 2012 Annual Report >>
View 2012 Proxy Statement >>